Canada Pension Plan Investment Board Lyell Immunopharma, Inc. Transaction History
Canada Pension Plan Investment Board
- $96.3 Billion
- Q2 2024
A detailed history of Canada Pension Plan Investment Board transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Canada Pension Plan Investment Board holds 588,235 shares of LYEL stock, worth $717,646. This represents 0.0% of its overall portfolio holdings.
Number of Shares
588,235
Previous 588,235
-0.0%
Holding current value
$717,646
Previous $1.31 Million
35.01%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding LYEL
# of Institutions
119Shares Held
145MCall Options Held
2.6KPut Options Held
7.5K-
Mwg Management Ltd. Washington, DC20.2MShares$24.6 Million31.93% of portfolio
-
Apoletto LTD Washington, DC15.1MShares$18.4 Million42.56% of portfolio
-
Orland Properties LTD Washington, DC15.1MShares$18.4 Million16.63% of portfolio
-
Black Rock Inc. New York, NY13.5MShares$16.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.4MShares$16.3 Million0.0% of portfolio
About Lyell Immunopharma, Inc.
- Ticker LYEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 247,824,992
- Market Cap $302M
- Description
- Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...